Prednisone: Clinical Trials

1,654 trials of Prednisone, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

797 completed, 205 unknown, 185 recruiting, 183 terminated. 806 Phase 2, 432 Phase 3, 280 Phase 1, 189 Phase 4, 95 Not applicable.

By phase and status

PhaseTrialsStatus
Phase 2806Completed 389, Recruiting 93, Terminated 91, Unknown 82, Active not recruiting 75, Not yet recruiting 37, Withdrawn 31, Suspended 5, Enrolling by invitation 3
Phase 3432Completed 216, Active not recruiting 48, Terminated 48, Unknown 45, Recruiting 42, Not yet recruiting 14, Withdrawn 13, Enrolling by invitation 4, Suspended 2
Phase 1280Completed 134, Terminated 39, Recruiting 36, Active not recruiting 30, Unknown 17, Not yet recruiting 11, Withdrawn 10, Suspended 2, Enrolling by invitation 1
Phase 4189Completed 86, Unknown 41, Recruiting 21, Terminated 18, Withdrawn 9, Not yet recruiting 7, Active not recruiting 4, Enrolling by invitation 2, Suspended 1
Not applicable95Completed 40, Unknown 28, Terminated 9, Recruiting 7, Not yet recruiting 5, Withdrawn 5, Active not recruiting 1
Early Phase 117Completed 6, Recruiting 5, Active not recruiting 2, Enrolling by invitation 1, Not yet recruiting 1, Terminated 1, Unknown 1

Follow Prednisone: new trials by email Literature Review of Prednisone trials Research Report on Prednisone

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
AMC 120, Glofitamab Plus Chemoimmunotherapy in Newly Diagnosed HIV-Associated Large B-Cell Lymphoma (The "Glofit-RCHOP Study")
Biopsy Procedure, Biospecimen Collection, Bone Marrow Aspiration - AIDS-Related Diffuse Large B-cell Lymphoma, Diffuse Large B-Cell Lymphoma, Not Otherwise Specified
Phase 1RecruitingNational Cancer Institute (NCI)152027-07-052026-11-05
Proactively Intervening On Early Cranial Nerve Injury As A Delayed Sequela Of Oropharyngeal Cancer: A Randomized Feasibility Clinical Trial For Pro-Habilitation (proNERVE RCT)
Prednisone, Ajovy, Manual Therapy - Cranial Nerve Injury, Oropharyngeal Cancer
Phase 1Not yet recruitingM.D. Anderson Cancer Center482027-03-012026-09-21
Molecular Evidence of Rejection Intervention Trial
Prednisone, Placebo - Heart Transplant Rejection
Not applicableNot yet recruitingCareDx2002027-03-012026-10-29
Testing the Use of High Dose Testosterone Followed by Darolutamide Compared to the Usual Care for Patients With Metastatic Prostate Cancer
Abiraterone Acetate, Biospecimen Collection, Bone Scan - Metastatic Castration-Resistant Prostate Adenocarcinoma, Stage IVB Prostate Cancer AJCC v8
Phase 2 / Phase 3Not yet recruitingECOG-ACRIN Cancer Research Group4322027-01-062026-10-01
Testing the Addition of an Anti-Cancer Drug, Glofitamab, to the Usual Chemotherapy Treatment (Alternating R-CHOP/R-DHAP) for Previously Untreated Mantle Cell Lymphoma
Biospecimen Collection, Cisplatin, Computed Tomography - Ann Arbor Stage II Mantle Cell Lymphoma, Ann Arbor Stage III Mantle Cell Lymphoma
Phase 1Not yet recruitingNational Cancer Institute (NCI)162026-12-302026-11-06
A Study to Evaluate Surovatamig Combined With R-CHOP in Participants of 18 to < 80 Years of Age With Previously Untreated Large B-cell Lymphoma With IPI Score 2 to 5
Surovatamig, Rituximab, Cyclophosphamide - Large B-cell Lymphoma
Phase 3Not yet recruitingAstraZeneca12002026-12-222026-11-02
MK-2870-U01 Substudy 1: A Clinical Trial of Sacituzumab Tirumotecan to Treat Prostate Cancer (MK-2870-01A)
Sacituzumab tirumotecan, Rescue medication, Docetaxel - Metastatic Castration-resistant Prostate Cancer
Phase 1 / Phase 2Not yet recruitingMerck Sharp & Dohme LLC2902026-12-142026-11-02
Epcoritamab and Pola-R-mini-CHP for the Treatment of Diffuse Large B Cell Lymphoma in Elderly or Unfit Patients
Biospecimen Collection, Computed Tomography, Cyclophosphamide - Diffuse Large B-Cell Lymphoma, Grade 3b Follicular Lymphoma
Phase 1Not yet recruitingJonsson Comprehensive Cancer Center202026-12-082026-07-20
ACT4RHD is an Open-label, Randomised, Adaptive Platform Trial to Evaluate Novel and Repurposed Clinical Interventions for Patients With Acute Rheumatic Fever and Carditis. ACT4RHD Seeks to Determine Whether These Interventions Reduce RHD Severity at 6 Months.
Hydroxychloroquine (HCQ), No Hydroxychloroquine (HCQ), Prednisone or Prednisolone - Rheumatic Fever, Rheumatic Heart Disease in Children
Phase 3Not yet recruitingStarship Child Health, Te Toka Tumai Auckland6002026-12-012026-10-07
Biomarker-Guided Mycophenolate Mofetil Elimination in Low-Risk Older Adult Kidney Transplant Recipients
Tacrolimus (Kidney transplant maintenance immunosuppression), Mycophenoate Mofetil, Prednisone (SOC arm) - Kidney Transplant Recipient
Early Phase 1Not yet recruitingVirginia Commonwealth University202026-12-012026-11-06
The CARDIOPROTECT Trial
Dexrazoxane, Dexrazoxane placebo, Doxorubicin - Diffuse Large B-cell Lymphoma (DLBCL), Cardiotoxicity
Phase 2Not yet recruitingBeth Israel Deaconess Medical Center602026-12-012026-11-06
Cemiplimab for Kidney Transplant Recipients With Advanced Cutaneous Squamous Cell Carcinoma
Cemiplimab, Prednisone, Sirolimus - Kidney Transplant Recipient, Cutaneous Squamous Cell Carcinoma (CSCC)
Phase 2Not yet recruitingWashington University School of Medicine222026-11-302026-10-15
Venetoclax Plus Inotuzumab Reduced-Intensity Induction Sequentially Followed by Blinatumomab in B-ALL
Inotuzumab ozogamicin (INO), Venetoclax (VEN), Vincristine - ALL
Not applicableNot yet recruitingInstitute of Hematology & Blood Diseases Hospital, China432026-11-302026-11-06
Evaluation of the Efficacy and Safety of Compound Betamethasone in Pulmonary Sarcoidosis
Prednisone, Compound betamethasone - Sarcoidosis, Pulmonary
Phase 2 / Phase 3Not yet recruitingPeking Union Medical College Hospital1262026-11-012026-10-15
Immunomodulatory Treatment of Interstitial Lung Disease Associated With Surfactant Related Gene Variants
Azithromycin 250 mg x3/week (3 tablets/week), Prednisone 10 mg/day, Hydroxychloroquine 400 mg/day - Interstitial Lung Disease
Phase 2Not yet recruitingAssistance Publique - Hôpitaux de Paris302026-11-012026-09-22
Testing the Addition of a New Anti-Cancer Drug, Glofitamab to Usual Chemotherapy for Burkitt and Double Hit Lymphoma
Biospecimen Collection, Bone Marrow Biopsy, Carboplatin - Recurrent Burkitt Lymphoma, Recurrent High Grade B-Cell Lymphoma With MYC and BCL2 Rearrangements
Phase 2 / Phase 3Not yet recruitingNational Cancer Institute (NCI)2712026-10-302026-08-19
Ivarmacitinib Versus Glucocorticoids in Mild-to-Moderate Systemic Lupus Erythematosus
Ivarmacitinib Sulfate Tablets, Prednisone Acetate Tablets - Systemic Lupus Erthematosus
Phase 2 / Phase 3Not yet recruitingChinese SLE Treatment And Research Group2942026-10-152026-09-11
Efficacy and Safety of Polatuzumab Vedotin, Rituximab Combined With Reduced-dose Cyclophosphamide, Doxorubicin and Prednisone Regimen in the Treatment of Elderly Patients With Diffuse Large B-cell Lymphoma: A Multicenter, Single-arm, Prospective Study
Polatuzumab Vedotin, Rituximab, Cyclophosphamide - Diffuse Large B-Cell Lymphoma
Phase 4RecruitingThe First Hospital of Jilin University262026-10-152026-11-02
Epcoritamab in Combination With Dose Adjusted EPOCH-R for High-risk Burkitt Lymphoma (BL), The BEDROCK Study
Biospecimen Collection, Bone Marrow Aspiration, Bone Marrow Biopsy - Adult Burkitt Lymphoma
Phase 2Not yet recruitingAIDS Malignancy Consortium432026-09-172026-10-16
Infliximab for Immune Checkpoint Inhibitor Associated AKI
Infliximab, Prednisone, prednisone (oral) - Acute Kidney Injury, Acute Interstitial Nephritis
Phase 4RecruitingMassachusetts General Hospital442026-09-152026-10-09

Showing 20 of 1654. Sign in to see all of them.

Conditions studied

Prostatic Neoplasms (246)  ·  Lymphoma (179)  ·  Lymphoma, Large B-Cell, Diffuse (178)  ·  Precursor Cell Lymphoblastic Leukemia-Lymphoma (88)  ·  Lymphoma, Follicular (81)  ·  Lymphoma, Non-Hodgkin (75)  ·  Burkitt Lymphoma (68)  ·  Multiple Myeloma (64)  ·  Leukemia (58)  ·  Hodgkin Disease (45)  ·  Lymphoma, Mantle-Cell (41)  ·  Neoplasms (35)  ·  Lymphoma, T-Cell, Peripheral (33)  ·  Lymphoma, B-Cell (31)  ·  Lymphoma, B-Cell, Marginal Zone (28)

Sponsors

National Cancer Institute (NCI) (83)  ·  M.D. Anderson Cancer Center (50)  ·  Children's Oncology Group (34)  ·  Janssen Research & Development, LLC (34)  ·  Hoffmann-La Roche (30)  ·  National Institute of Allergy and Infectious Diseases (NIAID) (27)  ·  Merck Sharp & Dohme LLC (25)  ·  SWOG Cancer Research Network (24)  ·  Sanofi (20)  ·  Assistance Publique - Hôpitaux de Paris (19)  ·  Ruijin Hospital (17)  ·  Dana-Farber Cancer Institute (16)  ·  Mayo Clinic (16)  ·  Memorial Sloan Kettering Cancer Center (16)  ·  Institute of Hematology & Blood Diseases Hospital, China (15)

Countries

United States (916)  ·  China (299)  ·  Canada (221)  ·  France (214)  ·  Italy (195)  ·  Spain (194)  ·  Germany (173)  ·  United Kingdom (170)  ·  Australia (162)  ·  Belgium (123)  ·  Poland (117)  ·  Netherlands (104)  ·  Israel (91)  ·  Czechia (85)  ·  Brazil (81)

Top investigators

Oliver W. Press, MD, PhD (6)  ·  Christopher J Melani, M.D. (5)  ·  Sandra J. Horning, MD (5)

Results publications

PMID 37505794, PMID 41671463, PMID 24722180, PMID 40135712, PMID 29272162, PMID 39121442, PMID 39319495, PMID 24970932, PMID 31221778, PMID 33693991, PMID 35230699, PMID 35882475, PMID 38446568, PMID 38864363, PMID 39058968, PMID 40016438, PMID 42020286, PMID 11807147, PMID 16105981, PMID 16407509, PMID 16421426, PMID 16754935, PMID 17654614, PMID 19433688, PMID 19546402, PMID 20007997, PMID 20032498, PMID 20154213, PMID 20600032, PMID 20661232, PMID 21719599, PMID 22337718, PMID 22747660, PMID 23228299, PMID 24224624, PMID 24344215, PMID 24687837, PMID 24787968, PMID 25135998, PMID 25685162, PMID 25829400, PMID 26031410, PMID 26248505, PMID 26609008, PMID 26867033, PMID 26888258, PMID 26913693, PMID 27282998, PMID 28426849, PMID 29148893

NIH funding

2023 (31), U10CA032102 (25), U10CA098543 (19), U10CA180886 (16), 2017 (14), U10CA021115 (13), 2009 (12), 2016 (10), 2015 (9), 2025 (9), U10CA031946 (9), U10CA180888 (9), 2019 (8), U10CA180820 (8), 2014 (7)